Case study

Using Medication Adherence Data to Predict Life Expectancy

Cross-Industry Collaboration: Data Bureau and Insurance

Objective

Determine the correlation between adherence to medication and increased longevity in patients, then leverage this insight to create risk scores for insurers.
 

Overview

In light of the growing prevalence of chronic diseases, there’s been an intensified focus on how patients comply with prescribed medication regimes.
 
With an ambition to ascertain if medication adherence could serve as a predictor for mortality risk, a prominent patient adherence company, boasting collaborations with over 500 pharmacies and nearly 30 pharmaceutical entities, teamed up with a census data provider:
 
  • Patient Adherence Company Dataset: This dataset originated from a patient adherence company which had collaborations with a vast network of pharmacies and pharmaceutical clients. The primary content of the dataset was information on the adherence to medication by patients, essentially capturing how consistently patients were taking their prescribed medication.
  • Data Bureau Dataset: This dataset was sourced from a data bureau. Its primary content was demographic and lifestyle data of the population, including vital statistics such as mortality or death records. This dataset would be able to indicate which individuals had passed away over a given period.
When the two datasets were overlapped using Omnisient’s Crypto-IDs, it allowed the researchers to identify the patients from the adherence dataset who had been marked as deceased in the census dataset.

Results achieved

Role of Medication Adherence in Prolonging Life

By comparing medication adherence levels of those who were deceased against those still alive, the researchers could discern the correlation between consistent medication adherence and reduced mortality rates. The data revealed that patients who stuck to their medication regimes were less likely to be among the deceased, suggesting a potential link between medication adherence and increased longevity.


This confirmed the hypothesis that patients with chronic conditions, when incentivized to remain consistent with their medication, can enhance their longevity. This insight also underscored the benefits such adherence could provide to life and health insurance providers.

The Impact

The Patient Adherence Company

Additional revenue and affirmed value proposition through its role in delivering patient adherence insights to larger healthcare and insurance ecosystems.

The Insurers

Insurers can incentivize medication adherence to effectively mitigating claim risks and realize financial benefits from a decrease in claims arising from mortality incidents and complications attributable to medication non-adherence.

The consumers

Patients can enjoy potential reductions in insurance premiums by consistently adhering to their medication, as well as enhanced quality of life and life-expectancy.

By linking medication adherence to longevity, they have paved the way for health insurance products to promote healthier behaviors and subsequently improve the quality of life for individuals with chronic conditions.  

Book a product demo

Let’s start the conversation about using 1st party consumer data to help you reach your optimal customers, reduce risk, and generate new revenue.

Book a demo with us